‌

US Patent 11083728 Compositions of cyclin dependent kinase 7 (CDK7) inhibitor

Patent 11083728 was granted and assigned to Syros Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Syros Pharmaceuticals

Current Assignee

Syros Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11083728

Date of Patent

August 10, 2021

Patent Application Number

20180403

Date Filed

April 3, 2018

Patent abstract

The present invention provides, in part, compositions comprising an inhibitor of cyclin-dependent kinase 7 (CDK7) and sulfobutyl ether-β-cyclodextrin. Also provided are methods of using a disclosed composition for treating proliferative diseases. The present invention also provides methods of making disclosed compositions.